1. Home
  2. RGP vs FATE Comparison

RGP vs FATE Comparison

Compare RGP & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$4.83

Market Cap

146.3M

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.11

Market Cap

131.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
FATE
Founded
1996
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.3M
131.5M
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
RGP
FATE
Price
$4.83
$1.11
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$6.00
$3.92
AVG Volume (30 Days)
349.9K
1.4M
Earning Date
01-02-2026
11-13-2025
Dividend Yield
5.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$534,625,000.00
$7,137,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.13
$0.66
52 Week High
$9.96
$2.93

Technical Indicators

Market Signals
Indicator
RGP
FATE
Relative Strength Index (RSI) 55.71 48.18
Support Level $4.71 $0.99
Resistance Level $4.89 $1.16
Average True Range (ATR) 0.20 0.08
MACD 0.02 0.01
Stochastic Oscillator 81.48 73.17

Price Performance

Historical Comparison
RGP
FATE

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: